EMD-45778

Single-particle
2.72 Å
EMD-45778 Deposition: 16/07/2024
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-45778

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9cof summary report (pdf.gz) Map-9cof FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of the full-length Measles virus Fusion protein E170G E455G in the pre-fusion conformation bound by [FIP-HRC]2-PEG11 in nanodisc

EMD-45778

Single-particle
2.72 Å
EMD-45778 Deposition: 16/07/2024
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Measles virus strain Ichinose-B95a, synthetic construct
Sample: Structure of the full-length Measles virus Fusion protein E170G E455G in the pre-fusion conformation bound by [FIP-HRC]2-PEG11 in nanodisc
Fitted models: 9cof

Deposition Authors: Zyla D , Saphire EO

Full-length soluble measles fusion glycoprotein as a new subunit vaccine strategy

Zyla D , Saphire EO
To Be Published